<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Aesthetics Product Guide</title>
	<link>http://blog.aestheticsproductguide.com</link>
	<description>A comprehensive guide to aesthetics products for medical professionals</description>
	<lastBuildDate>Mon, 27 Sep 2010 15:54:09 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.1.3" -->
	<item>
		<title>Benefits Of CyberKnife(R) Lung Radiosurgery Treatments Emphasized During Europe&#8217;s Largest Congress In Radiation Oncology</title>
		<description><![CDATA[Accuray Incorporated, announced that for the first time in Europe the company showcased its latest offering, the CyberKnife VSI System, at ESTRO 29; the Annual Congress of the European Society for Therapeutic Radiology and Oncology in Barcelona, Spain. Also featured at this meeting were multiple presentations demonstrating this system&#8217;s best-in-class motion management capabilities for lung [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/09/27/benefits-of-cyberknifer-lung-radiosurgery-treatments-emphasized-during-europes-largest-congress-in-radiation-oncology/</link>
			</item>
	<item>
		<title>New Randomized Controlled Trial Supports Efficacy And Safety Of Spiracur SNaP Wound Care System</title>
		<description><![CDATA[Spiracur, Inc. announced important results from a clinical study highlighting the efficacy of its SNaP Wound Care System for the treatment of chronic lower extremity wounds. The data was presented this week at the Fall 2010 Symposium on Advanced Wound Care (SAWC). The 12-center, 65-patient randomized controlled trial compared negative pressure wound therapy (NPWT) between [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/09/27/new-randomized-controlled-trial-supports-efficacy-and-safety-of-spiracur-snap-wound-care-system/</link>
			</item>
	<item>
		<title>Derma Sciences To Complete Enrollment In DSC127 Phase 2 Wound Healing Trial This Month</title>
		<description><![CDATA[Derma Sciences, Inc. has announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/09/23/derma-sciences-to-complete-enrollment-in-dsc127-phase-2-wound-healing-trial-this-month/</link>
			</item>
	<item>
		<title>New TotalFX Reduces Signs Of Aging In A Single Treatment</title>
		<description><![CDATA[Millions of Americans seek relief from the signs of an aging complexion, which includes fine lines, wrinkles, enlarged pores, age spots, sun spots and uneven skin tone and texture. Laser Clinique has announced TotalFX fractional laser resurfacing technique. This procedure is the latest treatment for painlessly and efficiently eliminating the signs of aging. For today&#8217;s [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/09/23/new-totalfx-reduces-signs-of-aging-in-a-single-treatment/</link>
			</item>
	<item>
		<title>Clove Oil Treatment For Itchy Rash</title>
		<description><![CDATA[A new study from the Queensland Institute of Medical Research (QIMR) has found that the major component of clove oil may be a promising lead as a new topical treatment for scabies. Plant essential oils have long been studied for their effects against mites, ticks, lice and mosquitoes. Researchers tested the clove oil and nutmeg [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/09/12/clove-oil-treatment-for-itchy-rash/</link>
			</item>
	<item>
		<title>BioAlliance Pharma Announces The Grant Of Its European Acyclovir Lauriad(R) Patent</title>
		<description><![CDATA[BioAlliance Pharma SA announced the grant of a European patent protecting its product acyclovir Lauriad®. This patent is now validated in all European countries; this first patent validation is a major step and the procedures up to the grant are ongoing in the other major global areas, America and Asia. This patent specifically protects the [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/09/12/bioalliance-pharma-announces-the-grant-of-its-european-acyclovir-lauriadr-patent/</link>
			</item>
	<item>
		<title>Medicis Announces Approval Of Additional Strengths Of Solodyn(R)</title>
		<description><![CDATA[Medicis announced that FDA has approved additional strengths of SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. The Company believes all forms of SOLODYN currently approved [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/09/08/medicis-announces-approval-of-additional-strengths-of-solodynr/</link>
			</item>
	<item>
		<title>Lytix Biopharma AS Announces Approval By Hungarian Authorities To Start Phase IIa Clinical Trial With LytixarTM In Gram Positive Skin Infections</title>
		<description><![CDATA[The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa clinical trial with LytixarTM (LTX-109) treatment of skin infections caused by Gram positive bacteria. Preclinical models have demonstrated that LytixarTM is strongly bactericidal, being equally effective against wild-type as well as drug-resistant bacteria such as MRSA. Because [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/09/08/lytix-biopharma-as-announces-approval-by-hungarian-authorities-to-start-phase-iia-clinical-trial-with-lytixartm-in-gram-positive-skin-infections/</link>
			</item>
	<item>
		<title>Spectral Molecular Imaging, Inc. Announces Accelerated Timeline For Its Early Melanoma Detection Product SkinSpect(TM)</title>
		<description><![CDATA[Cascade Technologies, Inc. announced that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. will complete development of its new product SkinSpect™, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010. The device incorporates new advances in component technologies, as well as experience derived from previous prototypes developed under federal funding and tested in [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/08/30/spectral-molecular-imaging-inc-announces-accelerated-timeline-for-its-early-melanoma-detection-product-skinspecttm/</link>
			</item>
	<item>
		<title>FDA Warns Of Possible Dangers From Portable Foot-Tanning Device</title>
		<description><![CDATA[The FDA is warning consumers about the risk of ultraviolet radiation overdose with the Tootsie Tanner portable foot tanning device. Use of the tanning device can lead to an overdose of ultraviolet radiation because its labeling recommends an improper duration of exposure to radiation and the device has an inadequate timer. The labeled exposure schedule [...]]]></description>
		<link>http://blog.aestheticsproductguide.com/2010/08/30/fda-warns-of-possible-dangers-from-portable-foot-tanning-device/</link>
			</item>
</channel>
</rss>

